EVAX

Evaxion A/S - ADR

3.28

USD

+0.01

+0.31%

Sep 23, 16:00 UTC -4

Closed

After-Market

3.30

+0.02

+0.64%

Evaxion A/S - ADR Profile

About

Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark.

Info & Links

CEO

Helen Tayton-Martin

Headquarters

Dr. Neergaards Vej 5F
Hoersholm, G7 2970, DENMARK

Auditor

EY Godkendt Revisionspartnerselskab

Share holders

Employees

Evaxion A/S - ADR Statistics

Valuation Measures

Market Capitalization²

29.78M

Enterprise Value

22.88M

Enterprise Value/EBITDA(ttm)

-27.81

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

2.81

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

Profit Margin(ttm)

15.41%

Return on Equity(ttm)

-61.43%

Return on Invested Capital(ttm)

4.64%

Return on Assets(ttm)

-34.23%

Income Statement

Revenue(ttm)

7.49M

Revenue Per Share(ttm)

Gross Profit(ttm)

7.49M

EBITDA(ttm)³

-823.00K

Net Income Available to Common(ttm)

-2.74M

Diluted EPS(ttm)

-1.21

Share Statistics

Beta (5Y Monthly)

0.26

52-Week Change

7.54%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

4.87M

% Held by Insiders

41.64%

% Held by Institutions

11.04%

Balance Sheet

Total Cash(mrq)

14.00M

Total Cash Per Share(mrq)

Total Debt(mrq)

7.11M

Total Debt/Equity(mrq)

74.55%

Current Ratio(mrq)

5.06%

Quick Ratio(mrq)

5.06%

Book Value Per Share(mrq)

1.14

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.11

Free Cash Flow(ytd)

-8.26M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.